Addex Therapeutics
ADXN
A$13.10
Share price
3.32%
Change (1 day)
7.18%
Change (1 year)
Categories
Revenue for Addex Therapeutics (ADXN)
Revenue in 2025 (TTM): A$0.28 Million
According to Addex Therapeutics's latest financial reports the company's current revenue (TTM 
) is A$0.29 Million. In 2024 the company made a revenue of A$0.72 Million a decrease over the revenue in the year 2023 that were of A$2.62 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Addex Therapeutics from 2019 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | A$0.28 M | -60.58% |
| 2024 | A$0.72 M | -72.35% |
| 2023 | A$2.62 M | 18.84% |
| 2022 | A$2.21 M | -48.82% |
| 2021 | A$4.32 M | -15.73% |
| 2020 | A$5.12 M | 27.71% |
| 2019 | A$4.01 M |